TAT4 Gel concentration B ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
265脂肪萎縮症1

265. 脂肪萎縮症


臨床試験数 : 112 薬物数 : 155 - (DrugBank : 55) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 97
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02647853
(ClinicalTrials.gov)
October 20143/1/2016Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy VolunteersA Randomized, Placebo-controlled, Double-blind, Multiple-ascending-dose, Phase 1 Study to Assess the Safety and Tolerability of TAT4 GelNasolabial Folds;Lipoatrophy;LipodystrophyDrug: TAT4 Gel concentration A;Drug: TAT4 Gel concentration B;Drug: PlaceboTopokine Therapeutics, Inc.NULLCompleted40 Years70 YearsBoth16Phase 1United States